Asia Pacific

Takeda Pharma and the Koch Institute for Integrative Cancer Research at MIT jointly announced that Takeda will support groundbreaking science in immuno-oncology at the Koch Institute. Over the next two years, the $1 million gift will help to build upon the research currently being conducted by the Institute to investigate…
WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec company, announced today the opening of a new commercial-scale cGMP biologics perfusion manufacturing facility in Wuxi city, China. In April 2015 WuXi Biologics announced plans to build a $150 million commercial biologics…
Pfizer Inc. will invest $350 million in eastern China on a plant for biotechnology drugs, bolstering its presence in the world’s second largest pharmaceutical market despite slowing economic growth in the country and rising pressure on prices for medicines.   The new facility in eastern Hangzhou city is expected to…
Alpha Biologics, a contract biomanufacturing service provider, commissioned a new cGMP biomanufacturing plant in April 2010. The plant, located at the Penang Biotech Park in Malaysia is dedicated to the production of mammalian cell secreted proteins. The plant broke ground in June 2006 and was built at an investment of…
The Jurong Island facility for the manufacture of enoxaparin sodium was opened in July 1999. Aventis commissioned the plant to meet the growing world demand for enoxaparin sodium, which had global sales in 2002 of €1.5 billion. Enoxaparin sodium was the first low-molecular-weight heparin to be introduced in the United…
Page 1 of 3

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: